CARBOPLATINE HOSPIRA 10 mg/ml, solution for infusion bottle, 15 ml
Active ingredients: Carboplatin
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusionbottle, 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARBOPLATINE HOSPIRA 10 mg/ml, solution injectable pour perfusion
- Pharmaceutical form
- solution injectable pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 15 ml protégé par un film plastique (Onco-Tain)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Mar 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66150794CIP75708028CIP133400957080280Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBOPLATINEsolution | 10 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.